References
- Napolitano M, Fabbrocini G, Marasca C, et al. Update on pathogenesis of hidradenitis suppurativa. G Ital Dermatol Venereol. 2018;153(3 Suppl 2):3–7.
- Simpson MA, Desai N, Trembath RC, et al. Gamma-Secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis. J Invest Dermatol. 2013;133:601–607.
- Antal AS, Dombrowski Y, Koglin S, et al. Impact of vitamin D3 on cutaneous immunity and antimicrobial peptide expression. Dermatoendocrinol. 2011;3(1):18–22.
- Samochocki Z, Bogaczewicz J, Jeziorkowska R, et al. Vitamin D effects in atopic dermatitis. J Am Acad Dermatol. 2013;69(2):238–244.
- Guillet A, Brocard A, Bach Ngohou K, et al. Verneuil’s disease, innate immunity and vitamin D: a pilot study. J Eur Acad Dermatol Venereol. 2015;29(7):1347–1353.
- Kelly G, Sweeney CM, Fitzgerald R, et al. Vitamin D status in hidradenitis suppurativa. Br J Dermatol. 170(6):1379–1380.
- Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Weaver CM: evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930.
- Balato A, Caiazzo G, Annunziata MC, et al. Anti-TNF-α therapy modulates mTORC1 signalling in hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2019;33(1):e43–e45.
- Marasca C, Donnarumma M, Annunziata MC, et al. Homocysteine plasma levels in patients affected by hidradenitis suppurativa: an Italian experience. Clin Exp Dermatol. 2019;44(3):e28–e29.